About
Lynn Calman is an Associate Professor in Nursing and Deputy Director of the Centre for Psychosocial Research in Cancer: CentRIC+ https://www.southampton.ac.uk/msrg/index.page in the School of Health Sciences at the University of Southampton.
Lynn is a registered adult and mental health nurse. In July 2020 she was appointed to the role of group manager within the pre-registration nursing team, leading a group of staff that integrate research and education.
External roles and appointments
- Executive Board member of the British Psychosocial Oncology Society (BPOS) https://www.bpos.org/
- Chair of the Advanced Disease and End of Life Care Workstream & Member of National Cancer Research Institute (NCRI) Living with and Beyond Cancer Executive Group
- Member of the National Cancer Research Institute (NCRI), Lung Cancer Group
- Member of the United Kingdom Association of Supportive Care in cancer (UKASCC) working group on Enhanced Supportive Care (ESC)
- Member of the International Psycho-Oncology Society (IPOS) Palliative Care Education Special Interest Group
Research
Research interests
- Over the last 15 years Lynn’s research has focused on understanding and responding to the needs of people living with and beyond cancer. She had led and collaborated on major research programmes in cancer survivorship/psychosocial oncology leading to widely published, practice changing findings that have underpinned the development of services to improve the outcomes of cancer patients.
Current research
As Deputy Director of the Centre for Psychosocial Research in Cancer: CentRIC+, Lynn collaborated on the development of a major psycho-oncology research programme at the University of Southampton, the HORIZONS Programme, funded by Macmillan Cancer Support. She was part of the team that developed RESTORE a web-based resource which aims to increase people's confidence to do things they want to do in spite of cancer related fatigue and collaborates on the ColoREctal Wellbeing (CREW) cohort study to explore recovery of health and wellbeing following primary treatment of colorectal cancer.
She also leads her own related programme of research focused on people living with advanced cancer. Lynn is Principal Investigator for the ENABLE study that aims to understand and characterise the importance of self-management support in people living with advanced cancer.
The MSRG team work closely with people affected by cancer as Research Partners in the development and conduct of research projects.
Research projects
Active projects
Completed projects
Publications
Supervision
Current PhD Students
Teaching
Lynn is the module lead for NPCG2037 Co-ordinating Long-Term Care in Partnership for second year, dual field, MN nursing students. She is also part of the module team for Palliative and End of Life Care (HLTH6158) for third and fourth year nursing students. Lynn teaches subject specialist content across other Health Sciences modules such as NPCG1028 Global and Public Health.
She is an Academic Assessor and personal academic tutor for pre-registration nursing students.
Lynn supervises students across a number of programmes including the BSc, MN, and MSc pre-registration nursing programmes, the MSc Physiotherapy (Pre-Registration) and post-registration MSc programmes.
Lynn is committed to research capacity building and developing psychosocial cancer care skills in the clinical workforce and takes an active role in seminars and events for clinicians. She the academic lead for work-based learning modules for CPD in cancer care.
Biography
Lynn undertook a degree in Nursing at the University of Edinburgh. She worked clinically in palliative and HIV/AIDS care, completed her education as a mental health nurse and worked in acute mental health before undertaking her doctorate at the University of Edinburgh. Lynn has held academic positions at the Universities of Glasgow and Manchester. Lynn joined the Macmillan Survivirship Research Group (now Centric+) in 2012 after completing an MRC post-doctoral fellowship in health services research and health of the public at the University of Manchester to develop an intervention for the follow-up of lung cancer patients after primary treatment.